188 related articles for article (PubMed ID: 17219198)
1. Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells.
Yang Y; Xiu F; Cai Z; Wang J; Wang Q; Fu Y; Cao X
J Cancer Res Clin Oncol; 2007 Jun; 133(6):389-99. PubMed ID: 17219198
[TBL] [Abstract][Full Text] [Related]
2. Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes.
Xiu F; Cai Z; Yang Y; Wang X; Wang J; Cao X
J Mol Med (Berl); 2007 May; 85(5):511-21. PubMed ID: 17219095
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
Hao S; Bai O; Yuan J; Qureshi M; Xiang J
Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
[TBL] [Abstract][Full Text] [Related]
4. Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity.
Hao S; Ye Z; Yang J; Bai O; Xiang J
Cancer Biother Radiopharm; 2006 Apr; 21(2):146-54. PubMed ID: 16706635
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo.
Toyota H; Yanase N; Yoshimoto T; Harada M; Kato Y; Mizuguchi J
Oncol Rep; 2015 Jan; 33(1):292-6. PubMed ID: 25394516
[TBL] [Abstract][Full Text] [Related]
7. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity.
Zhang H; Xie Y; Li W; Chibbar R; Xiong S; Xiang J
Cell Mol Immunol; 2011 Jan; 8(1):23-30. PubMed ID: 21200381
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
9. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells.
Dai S; Zhou X; Wang B; Wang Q; Fu Y; Chen T; Wan T; Yu Y; Cao X
J Mol Med (Berl); 2006 Dec; 84(12):1067-76. PubMed ID: 17016692
[TBL] [Abstract][Full Text] [Related]
10. Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces antitumor immune response in vitro.
Zhang J; Zhang Y; Luo C; Xia Y; Chen H; Wu X
Tumori; 2010; 96(3):452-9. PubMed ID: 20845808
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X
Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399
[TBL] [Abstract][Full Text] [Related]
12. Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1.
Guo J; Chen T; Wang B; Zhang M; An H; Guo Z; Yu Y; Qin Z; Cao X
Immunol Lett; 2003 Oct; 89(1):1-7. PubMed ID: 12946858
[TBL] [Abstract][Full Text] [Related]
13. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.
Lee YS; Kim SH; Cho JA; Kim CW
Exp Mol Med; 2011 May; 43(5):281-90. PubMed ID: 21464590
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of renal cancer vaccine of IL-12-anchored exosomes and its antitumor effect in vitro].
Zhang Y; Wu XH; Chen G; Luo CL; Zhang JM
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):339-43. PubMed ID: 20723430
[TBL] [Abstract][Full Text] [Related]
15. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
Hao S; Bai O; Li F; Yuan J; Laferte S; Xiang J
Immunology; 2007 Jan; 120(1):90-102. PubMed ID: 17073943
[TBL] [Abstract][Full Text] [Related]
16. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
17. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine.
Chen T; Guo J; Yang M; Zhu X; Cao X
J Immunol; 2011 Feb; 186(4):2219-28. PubMed ID: 21242526
[TBL] [Abstract][Full Text] [Related]
18. Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity.
Visseren MJ; Koot M; van der Voort EI; Gravestein LA; Schoenmakers HJ; Kast WM; Zijlstra M; Melief CJ
J Immunother Emphasis Tumor Immunol; 1994 Feb; 15(2):119-28. PubMed ID: 8136944
[TBL] [Abstract][Full Text] [Related]
19. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
Dai S; Wan T; Wang B; Zhou X; Xiu F; Chen T; Wu Y; Cao X
Clin Cancer Res; 2005 Oct; 11(20):7554-63. PubMed ID: 16243831
[TBL] [Abstract][Full Text] [Related]
20. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
